Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Long-Term Deferred Tax (2016 - 2019)

Historic Long-Term Deferred Tax for Harvard Bioscience (HBIO) over the last 11 years, with Q2 2019 value amounting to $210000.0.

  • Harvard Bioscience's Long-Term Deferred Tax rose 1864.41% to $210000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $210000.0, marking a year-over-year increase of 1864.41%. This contributed to the annual value of $182000.0 for FY2017, which is 10346.01% up from last year.
  • According to the latest figures from Q2 2019, Harvard Bioscience's Long-Term Deferred Tax is $210000.0, which was up 1864.41% from $208000.0 recorded in Q1 2019.
  • In the past 5 years, Harvard Bioscience's Long-Term Deferred Tax registered a high of $11.0 million during Q3 2015, and its lowest value of -$5.3 million during Q4 2016.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $954000.0 (2016), whereas its average is $1.8 million.
  • As far as peak fluctuations go, Harvard Bioscience's Long-Term Deferred Tax crashed by 12494.62% in 2015, and later surged by 10346.01% in 2017.
  • Over the past 5 years, Harvard Bioscience's Long-Term Deferred Tax (Quarter) stood at -$5.0 million in 2015, then decreased by 5.54% to -$5.3 million in 2016, then skyrocketed by 103.46% to $182000.0 in 2017, then decreased by 1.65% to $179000.0 in 2018, then rose by 17.32% to $210000.0 in 2019.
  • Its last three reported values are $210000.0 in Q2 2019, $208000.0 for Q1 2019, and $179000.0 during Q3 2018.